← Leaderboards
Patrick Franklin Kiser
University Of Utah
$17,126,760
Attributed
$26,972,321
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.7M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$26,972,321 · 7
By mechanism
UM1$17,890,653 · 1
U19$6,850,889 · 3
R33$1,386,432 · 1
R21$844,347 · 2
Top collaborators
- Thomas Hope5 shared
- Rodney J.Y. Ho5 shared
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsWomanPharmaceutical PreparationsBaseDesignVaginaIn VitroIn VivoEvaluationMicrobicideDrug KineticsLeadMacacaTenofovirDrug FormulationsAids PreventionHiv InfectionsResearch StudyTissuesPerformanceSeriesHiv-1PhysiologicalSeminal Fluid
Grant awards (27)
Sustained Long Acting Prevention Against HIV Program Operation$3,346,920
UM1 · FY2019 · AI
Sustained Long Acting Prevention Against HIV Program Operation$3,501,400
UM1 · FY2018 · AI
Sustained Long Acting Prevention Against HIV Program Operation$3,525,315
UM1 · FY2017 · AI
Pharmacokinetics and Biodistribution of Antiretrovirals and HIV-1 in Macaques$138,535
U19 · FY2017 · AI · contact PI
Sustained Long Acting Prevention Against HIV Program Operation$3,907,549
UM1 · FY2016 · AI
Pharmacokinetics and Biodistribution of Antiretrovirals and HIV-1 in Macaques$785,977
U19 · FY2016 · AI · contact PI
Sustained Long Acting Prevention Against HIV Program Operation$3,609,469
UM1 · FY2015 · AI
Pharmacokinetics and Biodistribution of Antiretrovirals and HIV-1 in Macaques$656,537
U19 · FY2015 · AI · contact PI
Pharmacokinetics and Biodistribution of Antiretrovirals and HIV-1 in Macaques$223,743
U19 · FY2015 · AI · contact PI
Pharmacokinetics and Biodistribution of Antiretrovirals and HIV-1 in Macaques$761,171
U19 · FY2014 · AI · contact PI
Pharmacokinetics and Biodistribution of Antiretrovirals and HIV-1 in Macaques$646,002
U19 · FY2013 · AI · contact PI
Bioresponsive Combination Microbicide Delivery System for HIV and HSV$493,043
R33 · FY2013 · AI · contact PI
Sustained Intravaginal Delivery Technologies Against HIV and HSV$673,111
U19 · FY2012 · AI · contact PI
Bioresponsive Combination Microbicide Delivery System for HIV and HSV$431,949
R33 · FY2012 · AI · contact PI
Delivery Systems for Long Acting Combination Microbicides$166,076
U19 · FY2012 · AI · contact PI
Bioresponsive Combination Microbicide Delivery System for HIV and HSV$461,440
R33 · FY2011 · AI · contact PI
Sustained Intravaginal Delivery Technologies Against HIV and HSV$407,939
U19 · FY2011 · AI · contact PI
Delivery Systems for Long Acting Combination Microbicides$196,739
U19 · FY2011 · AI · contact PI
Sustained Intravaginal Delivery Technologies Against HIV and HSV$514,290
U19 · FY2010 · AI · contact PI
Delivery Systems for Long Acting Combination Microbicides$348,514
U19 · FY2010 · AI · contact PI
Bioresponsive Combination Microbicide Delivery System for HIV and HSV$226,278
R21 · FY2010 · AI · contact PI
Sustained Intravaginal Delivery Technologies Against HIV and HSV$589,781
U19 · FY2009 · AI · contact PI
Delivery Systems for Long Acting Combination Microbicides$343,939
U19 · FY2009 · AI · contact PI
Bioresponsive Combination Microbicide Delivery System for HIV and HSV$187,760
R21 · FY2009 · AI · contact PI
Delivery Systems for Long Acting Combination Microbicides$398,535
U19 · FY2008 · AI · contact PI
Bioresponsive Microbicides for AIDS Prevention$186,875
R21 · FY2005 · AI
Bioresponsive Microbicides for AIDS Prevention$243,434
R21 · FY2004 · AI